학술논문
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification
Document Type
Article
Author
Goddard, J.; Castle, J.; Southworth, E.; Fletcher, A.; Crosier, S.; Richardson, S.; Hill, R.M.; Williamson, D.; Bailey, S.; Schwalbe, E.C.; Clifford, S.C.; Hicks, D.; Martin-Guerrero, I.; García-Ariza, M.; Navajas, A.; Masliah-Planchon, J.; Bourdeaut, F.; Dufour, C.; Ayrault, O.; Goschzik, T.; Pietsch, T.; Sill, M.; Pfister, S.M.; Rutkowski, S.
Source
In: Acta Neuropathologica . (Acta Neuropathologica, May 2023, 145(5):651-666)
Subject
Language
English
ISSN
14320533
00016322
00016322